MedTrace Logo

Transcutaneous Pulsed Radiofrequency in Migraine

NCT05499689 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-02-03

No results posted yet for this study

Summary

The aim of the investigator is to compare the efficacy of greater occipital nerve block and transcutaneous pulsed radiofrequency treatment in migraine.

Conditions

  • Migraine Disorders

Interventions

DRUG

Bupivacaine Hydrochloride

2.5 cc bupivacain injection will be administered by approaching the greater occipital nerve under ultrasound guidance.

OTHER

Transcutaneous pulsed radiofrequency qurrent

Pulsed radiofrequency current will be applied through transcutaneous pads adhered over the greater occipital nerve trace on the nape.

Sponsors & Collaborators

  • Diskapi Teaching and Research Hospital

    lead OTHER

Principal Investigators

  • mehlika panpallı ateş · Diskapi TRH

  • ömer taylan akkaya · Diskapi TRH

  • Hüseyin Alp Alptekin · Diskapi TRH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-22
Primary Completion
2023-06-22
Completion
2023-08-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05499689 on ClinicalTrials.gov